Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -2.179% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a.) CCC1=NN(C(=O)Cc2ccc([N+](=O)[O-])cc2)C(O)(c2ccncc2)C1
b.) Clc1ccc2nc(-c3ccc4c(c3)OCO4)cn2c1
c.) CCCCn1c(-c2ccc([N+](=O)[O-])cc2)n[nH]c1=S
d.) CC(C)C(=O)Nc1ccc(NC(=O)c2cccc(F)c2)cn1
Answer: d. CC(C)C(=O)Nc1ccc(NC(=O)c2cccc(F)c2)cn1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)C(=O)Nc1ccc(NC(=O)c2cccc(F)c2)cn1
CC(C)C(=O)Nc1ccc(NC(=O)c2cccc(F)c2)cn1
3-fluoro-N-[6-(2-methylpropanoylamino)pyridin-3-yl]benzamide